Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ

Yasoo Sugiura, Takayuki Morikawa, Toshiki Takenouchi, Makoto Suematsu, Mayumi Kajimura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Although cilostazol, a phosphodiesterase 3 inhibitor, has been suggested to strengthen the endothelial barrier using cultured endothelial monolayers, its effect has not been tested in vivo. We, therefore, investigated effects of cilostazol on barrier properties of postcapillary venules of the rat in situ. Methods: Cilostazol was administered to the rats through oral gavage at 4 hours before the measurements. The hydraulic permeability (Lp) and the effective osmotic pressure ((Formula presented.)), molecular sieving properties of microvascular walls, were estimated in single mesenteric postcapillary venules by a micro-occlusion technique, first during control perfusion and then in the presence of histamine. Results: When the vessels were inflamed with histamine, cilostazol attenuated a transient increase in Lp and prevented (Formula presented.) from falling. Furthermore, it reduced baseline Lp under a control state. Conclusion: Cilostazol appears to tighten the endothelial barrier in situ, at least in part by inhibiting the cAMP-degrading enzyme in the endothelium.

Original languageEnglish
Pages (from-to)594-599
Number of pages6
JournalPhlebology
Volume29
Issue number9
DOIs
Publication statusPublished - 2014

Fingerprint

Mesentery
Venules
Histamine
Phosphodiesterase 3 Inhibitors
Osmotic Pressure
Endothelium
Permeability
Perfusion
cilostazol
Enzymes

Keywords

  • antiplatelet drugs
  • Microvascular permeability
  • phosphodiesterase 3

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ. / Sugiura, Yasoo; Morikawa, Takayuki; Takenouchi, Toshiki; Suematsu, Makoto; Kajimura, Mayumi.

In: Phlebology, Vol. 29, No. 9, 2014, p. 594-599.

Research output: Contribution to journalArticle

@article{d966cc256fc74019b469e31a3b580df3,
title = "Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ",
abstract = "Objective: Although cilostazol, a phosphodiesterase 3 inhibitor, has been suggested to strengthen the endothelial barrier using cultured endothelial monolayers, its effect has not been tested in vivo. We, therefore, investigated effects of cilostazol on barrier properties of postcapillary venules of the rat in situ. Methods: Cilostazol was administered to the rats through oral gavage at 4 hours before the measurements. The hydraulic permeability (Lp) and the effective osmotic pressure ((Formula presented.)), molecular sieving properties of microvascular walls, were estimated in single mesenteric postcapillary venules by a micro-occlusion technique, first during control perfusion and then in the presence of histamine. Results: When the vessels were inflamed with histamine, cilostazol attenuated a transient increase in Lp and prevented (Formula presented.) from falling. Furthermore, it reduced baseline Lp under a control state. Conclusion: Cilostazol appears to tighten the endothelial barrier in situ, at least in part by inhibiting the cAMP-degrading enzyme in the endothelium.",
keywords = "antiplatelet drugs, Microvascular permeability, phosphodiesterase 3",
author = "Yasoo Sugiura and Takayuki Morikawa and Toshiki Takenouchi and Makoto Suematsu and Mayumi Kajimura",
year = "2014",
doi = "10.1177/0268355513497361",
language = "English",
volume = "29",
pages = "594--599",
journal = "Phlebology",
issn = "1433-3031",
publisher = "SAGE Publications Ltd",
number = "9",

}

TY - JOUR

T1 - Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ

AU - Sugiura, Yasoo

AU - Morikawa, Takayuki

AU - Takenouchi, Toshiki

AU - Suematsu, Makoto

AU - Kajimura, Mayumi

PY - 2014

Y1 - 2014

N2 - Objective: Although cilostazol, a phosphodiesterase 3 inhibitor, has been suggested to strengthen the endothelial barrier using cultured endothelial monolayers, its effect has not been tested in vivo. We, therefore, investigated effects of cilostazol on barrier properties of postcapillary venules of the rat in situ. Methods: Cilostazol was administered to the rats through oral gavage at 4 hours before the measurements. The hydraulic permeability (Lp) and the effective osmotic pressure ((Formula presented.)), molecular sieving properties of microvascular walls, were estimated in single mesenteric postcapillary venules by a micro-occlusion technique, first during control perfusion and then in the presence of histamine. Results: When the vessels were inflamed with histamine, cilostazol attenuated a transient increase in Lp and prevented (Formula presented.) from falling. Furthermore, it reduced baseline Lp under a control state. Conclusion: Cilostazol appears to tighten the endothelial barrier in situ, at least in part by inhibiting the cAMP-degrading enzyme in the endothelium.

AB - Objective: Although cilostazol, a phosphodiesterase 3 inhibitor, has been suggested to strengthen the endothelial barrier using cultured endothelial monolayers, its effect has not been tested in vivo. We, therefore, investigated effects of cilostazol on barrier properties of postcapillary venules of the rat in situ. Methods: Cilostazol was administered to the rats through oral gavage at 4 hours before the measurements. The hydraulic permeability (Lp) and the effective osmotic pressure ((Formula presented.)), molecular sieving properties of microvascular walls, were estimated in single mesenteric postcapillary venules by a micro-occlusion technique, first during control perfusion and then in the presence of histamine. Results: When the vessels were inflamed with histamine, cilostazol attenuated a transient increase in Lp and prevented (Formula presented.) from falling. Furthermore, it reduced baseline Lp under a control state. Conclusion: Cilostazol appears to tighten the endothelial barrier in situ, at least in part by inhibiting the cAMP-degrading enzyme in the endothelium.

KW - antiplatelet drugs

KW - Microvascular permeability

KW - phosphodiesterase 3

UR - http://www.scopus.com/inward/record.url?scp=84906880528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906880528&partnerID=8YFLogxK

U2 - 10.1177/0268355513497361

DO - 10.1177/0268355513497361

M3 - Article

VL - 29

SP - 594

EP - 599

JO - Phlebology

JF - Phlebology

SN - 1433-3031

IS - 9

ER -